Page last updated: 2024-12-07
1-(4,6-propyl)dihydroalprenolol
You're asking about a compound that doesn't exist as described. Let's break down why:
* **1-(4,6-propyl)dihydroalprenolol** is a chemical name that doesn't make sense. Here's why:
* **Dihydroalprenolol (DHA)** is a well-known beta-blocker drug.
* **Propyl** refers to a 3-carbon chain (CH3CH2CH3).
* **4,6** implies a specific location on a molecule, but dihydroalprenolol's structure doesn't have positions labeled 4 and 6.
**It's likely you're asking about a compound with a similar structure to dihydroalprenolol that has been modified by adding a propyl group. **
To give you a helpful answer, I need more information:
* **What is the actual structure of the molecule you're interested in?** A chemical drawing or a more detailed name would be very useful.
* **What is the research question you are investigating?** Knowing the context will help me understand why you're interested in this particular molecule.
Once I have this information, I can provide you with more details about the compound and its potential importance in research.
Cross-References
ID Source | ID |
PubMed CID | 129515 |
MeSH ID | M0159934 |
Synonyms (7)
Synonym |
3h-dha |
1-(propan-2-ylamino)-3-(2,4,6-tripropylphenoxy)propan-2-ol |
1-(4,6-propyl)dihydroalprenolol |
2-propanol, 1-((1-methylethyl)amino)-3-(2,4,6-tripropylphenoxy)- |
121864-88-8 |
1-[(propan-2-yl)amino]-3-(2,4,6-tripropylphenoxy)propan-2-ol |
DTXSID30923995 |
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
pre-1990 | 1 (20.00) | 18.7374 |
1990's | 3 (60.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (20.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.87
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
Metric | This Compound (vs All) |
---|
Research Demand Index | 12.87 (24.57) | Research Supply Index | 1.79 (2.92) | Research Growth Index | 4.66 (4.65) | Search Engine Demand Index | 0.00 (26.88) | Search Engine Supply Index | 0.00 (0.95) |
| |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |